Delivery Order SPE2DB25D3002-SPE2DB25FLPZB

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LUPRON DEPOT-PED 30 MG 3MO KITS to the Defense Logistics Agency (DLA). The $25,478.46 firm-fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of May 28, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,904.96 firm fixed-price delivery order is for the supply of LUPRON DEPOT-PED 30 MG 3MO KITS, a specialty medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $9,141.81 firm fixed-price contract is for the delivery of LUPRON DEPOT-PED 30 MG 3MO KITS, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award is a delivery order valued at $129,142.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, with a performance period that runs through December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,385.87, is for the provision of LUPRON DEPOT-PED 11.25 MG KITS, a specialty medication, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563588576 LUPRON DEPOT-PED 11.25 MG KITS. The award has a potential value of $17,468.47 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. This delivery order is issued under an indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $4,926.04 to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, with a performance period ending on May 10, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LUPRON DEPOT 3.75 MG KITS. The $10,074.90 firm fixed price contract has an ultimate completion date of April 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of 4565294531 units of LUPRON DEPOT-PED 11.25 MG KITS. The contract is a delivery order with a firm fixed price of $54,082.84 and an ultimate completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distribution company, is the prime contractor and there is no set-aside designation for this award. This contract is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LUPRON DEPOT-PED 30 MG 3MO KITS. The contract has a firm fixed price of $127,190.84 and a period of performance through September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLPZB
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of LUPRON DEPOT-PED 15 MG KITS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $6,411.57, has a completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition. The contract supports the DLA's mission of providing essential medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/4/25, 12:58 AM